Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Phase II trial for F2G’s antifungal drug following EU approval

europeanpharmaceuticalreviewJanuary 13, 2017

Tag: F2G’s antifungal , trial for

PharmaSources Customer Service